P092 QOL score changes in breast cancer patients: 2-year vs. 3-or-more-year administration of leuprorelin. (March 2015) - Ohashi, Y.; Shiba, E.; Toyama, T.; Kurebayashi, J.; Noguchi, S.; Iwase, H.